ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)

Clinical trial NCT03759340 · TERMINATED

Trial details

NCT number: NCT03759340
Sponsor: Aclaris Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Alopecia Areata Alopecia Universalis Alopecia Totalis

Start date: 2019-01-15
Primary completion: 2019-09-11
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.